Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $17,869 | 4 | 91.9% |
| Travel and Lodging | $1,100 | 4 | 5.7% |
| Food and Beverage | $472.99 | 5 | 2.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $17,869 | 4 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,573 | 9 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $503.00 | 1 | Eli Lilly and Company ($503.00) |
| 2021 | $788.42 | 1 | Eli Lilly and Company ($788.42) |
| 2020 | $16,578 | 2 | Eli Lilly and Company ($16,578) |
| 2017 | $1,573 | 9 | Novartis Pharmaceuticals Corporation ($1,573) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/23/2022 | Eli Lilly and Company | — | — | In-kind items and services | $503.00 | Research |
| Study: ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE | ||||||
| 01/26/2021 | Eli Lilly and Company | — | — | In-kind items and services | $788.42 | Research |
| Study: ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE | ||||||
| 06/10/2020 | Eli Lilly and Company | — | — | In-kind items and services | $1,077.94 | Research |
| Study: ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE | ||||||
| 06/08/2020 | Eli Lilly and Company | — | — | Cash or cash equivalent | $15,500.00 | Research |
| Study: ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE | ||||||
| 11/17/2017 | Novartis Pharmaceuticals Corporation | CNP520 (Drug) | Food and Beverage | In-kind items and services | $102.52 | General |
| 11/16/2017 | Novartis Pharmaceuticals Corporation | CNP520 (Drug) | Travel and Lodging | In-kind items and services | $465.92 | General |
| 11/16/2017 | Novartis Pharmaceuticals Corporation | CNP520 (Drug) | Food and Beverage | In-kind items and services | $124.67 | General |
| 11/16/2017 | Novartis Pharmaceuticals Corporation | CNP520 (Drug) | Food and Beverage | In-kind items and services | $114.99 | General |
| 11/16/2017 | Novartis Pharmaceuticals Corporation | CNP520 (Drug) | Travel and Lodging | Cash or cash equivalent | $77.88 | General |
| 11/16/2017 | Novartis Pharmaceuticals Corporation | CNP520 (Drug) | Travel and Lodging | In-kind items and services | $45.00 | General |
| 11/16/2017 | Novartis Pharmaceuticals Corporation | CNP520 (Drug) | Food and Beverage | Cash or cash equivalent | $11.10 | General |
| 11/15/2017 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $511.00 | General |
| 11/15/2017 | Novartis Pharmaceuticals Corporation | CNP520 (Drug) | Food and Beverage | In-kind items and services | $119.71 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE | Eli Lilly and Company | $17,869 | 4 |
About Dr. Peter Boxer, M.D
Dr. Peter Boxer, M.D is a Psychiatry healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437155090.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Boxer, M.D has received a total of $19,442 in payments from pharmaceutical and medical device companies, with $503.00 received in 2022. These payments were reported across 13 transactions from 2 companies. The most common payment nature is "" ($17,869).
Practice Information
- Specialty Psychiatry
- Location Cincinnati, OH
- Active Since 06/28/2005
- Last Updated 11/04/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1437155090
Products in Payments
- CNP520 (Drug) $1,062
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Cincinnati
Henry Nasrallah, Md, MD
Psychiatry — Payments: $4.0M
Dr. Tracey Skale, M.d, M.D
Psychiatry — Payments: $652,367
Paul Keck, Md, MD
Psychiatry — Payments: $568,675
Dr. Caleb Adler, Md, MD
Psychiatry — Payments: $133,953
Helen Farrell, Md, MD
Psychiatry — Payments: $132,909
Melissa Delbello, Md, MD
Psychiatry — Payments: $104,547